Providing thought-provoking leadership, workplace and community insights.
We understand how time constraints conflict with your need to follow industry trends. Please
subscribe here and we’ll notify you when we periodically post articles and news briefs.
By Jeffrey Jacobs, M.D., M.P.H.
In my role as a Medical Review Officer (MRO), I recently reviewed a case involving a job applicant who walked out in the middle of the drug screening process.
He provided an insufficient amount of urine for testing (45 mL) and left the clinic after 30 minutes.
Drug screening protocol calls for offering a donor who does not produce a testable specimen up to 40 oz. of water and directing him or her to urinate within three hours of providing the initial specimen. Once a second specimen is produced, the original specimen is usually discarded.
In this case, the specimen collector documented the donor’s departure from the clinic on the chain of custody and control form. Upon reviewing the form, I designated this case as a “Refusal to Test” and informed the client.
What Constitutes Refusal to Test?
In general, refusal to test is a conscious attempt on the part of the donor to fraudulently pass the test. The collector, the laboratory or the MRO can declare it in all three steps of the drug testing process.
Per 49 CFR, Part 40, Section 40.191, Subpart I, Problems in Drug Tests, that may mean the donor has not provided a sufficient quantity of urine to test. Alternatively, it may mean the donor:
Most individuals pass their drug tests without incident. Individuals who appear to be overly anxious, act suspiciously, are argumentative or seek to delay or extend the process should be treated in a firm but respectful manner and held to the same standard as others. The test must be completed in a timely manner for all donors.
A weak link in the screening process is often found at collection sites where collectors allow questionable donor behavior to go unacknowledged or undocumented. In this case the collectors followed correct procedures. Presumably the applicant who left before providing a second specimen will not be hired.
We recommend working with a reliable provider to ensure the drug testing process runs smoothly and discourages anyone who may consider trying to cheat on a test.
Did You Know?
Showing up late or not showing up at all is not considered a refusal to test in post-offer drug screening situations.
Dr. Jacobs is an Associate Medical Director and Vice President, Clinical Services, Medical Exams & Travel, WorkCare, Inc.
As segments of the country reopen during the COVID-19 pandemic, many employees are returning to...
Liberty Mutual Insurance publishes an annual Workplace Safety Index on the top causes of disabling...
WorkCare has introduced an affordable online course for employers on Return to Work During the...
By Peter P. Greaney, M.D. WorkCare Executive Chairman and Chief Medical Officer A great deal...
When you subscribe you’ll receive links to blog posts, newsletters, fact sheets, articles, news briefs and videos by email when we post them.